SCHEMBL15475178

SCHEMBL15475178

CN(C)c1[c]cc(-c2ccccc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.41
ALDH1A1 P00352 3/20 0.38
CHKA P35790 2/20 0.36
USP2 O75604 2/20 0.35
KDM4E B2RXH2 1/20 0.35
CYP1A2 P05177 2/20 0.34
MAPK1 P28482 1/20 0.34
CYP3A4 P08684 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
MMP3 P08254 1/20 0.34
BCL2L1 Q07817 1/20 0.34
LSS P48449 1/20 0.34
PYCR1 P32322 1/20 0.33
NPC1 O15118 1/20 0.33
TP53 P04637 1/20 0.33
PKM P14618 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CYP1A1 P04798 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28424806 0.72 TAAR1 (0.57) TAAR1ALDH1A1CHKAUSP2KDM4E
SCHEMBL457428 0.71 ALDH1A1 (0.43) TAAR1ALDH1A1CYP1A2MAPK1CYP3A4
SCHEMBL3302867 0.69 ALDH1A1 (0.36) TAAR1ALDH1A1CHKAUSP2MAPK1
Tannin Pyrogallol SCHEMBL11548899 0.69 ALDH1A1 (0.60) TAAR1ALDH1A1USP2KDM4ECYP1A2
SCHEMBL8660579 0.69 ALDH1A1 (0.40) ALDH1A1TDP1
SCHEMBL2448169 0.69 ALDH1A1 (0.45) TAAR1ALDH1A1CYP1A2MAPK1CYP3A4
SCHEMBL2958548 0.69 ALDH1A1 (0.45) TAAR1ALDH1A1CYP1A2MAPK1CYP3A4
SCHEMBL2779576 0.69 ALDH1A1 (0.48) ALDH1A1CHKAKDM4EMAPK1CYP3A4
SCHEMBL1074262 0.68 PTGS2 (0.39) TAAR1ALDH1A1CYP1A2MAPK1CYP3A4
Biphenyl SCHEMBL6740039 0.68 ALDH1A1 (0.69) TAAR1ALDH1A1USP2KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021006267-A1 SALT OF PYRAZOLE DERIVATIVE AND PREPARATION OF PYRAZOLE DERIVATIVE グリーン・テック株式会社 2021-01-14 WO disclosed
CN-112105611-A Pharmaceutical combination comprising a Histone Deacetylase (HDAC) inhibitor and a TLR7 agonist and/or a TLR8 agonist for the treatment of cancer 4SC股份公司 2020-12-18 CN disclosed
CN-112055589-A Combination comprising an HDAC inhibitor, a LAG-3 inhibitor and a PD-1 inhibitor or a PD-L1 inhibitor for the treatment of cancer 4SC股份公司 2020-12-08 CN disclosed
CN-112004535-A Combination comprising an HDAC inhibitor and a CD137 agonist for cancer therapy 4SC股份公司 2020-11-27 CN disclosed
WO-2020235582-A1 PREVENTIVE AND/OR THERAPEUTIC AGENT FOR MOTOR NEURON DISEASE グリーン・テック株式会社 (JP) 2020-11-26 WO disclosed
CN-111432884-A Combination of HDAC inhibitors with immune checkpoint modulators for cancer therapy 4SC股份公司 2020-07-17 CN disclosed
EP-3323816-A1 NOVEL PYRAZOLE DERIVATIVE Green Tech Co., Ltd. (JP) 2018-05-23 EP disclosed
CN-107001822-A Film-forming ink, film-forming method, device having film, and electronic device 精工爱普生株式会社 2017-08-01 CN disclosed
US-9399635-B2 Pyrazole derivative GREEN TECH CO., LTD. (JP) 2016-07-26 US disclosed
US-20140088029-A1 NOVEL PYRAZOLE DERIVATIVE PHARMA EIGHT CO., LTD. (JP) 2014-03-27 US disclosed
EP-2698368-A1 NOVEL PYRAZOLE DERIVATIVE Pharma Eight Co. Ltd (JP) 2014-02-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140088029-A1 NOVEL PYRAZOLE DERIVATIVE PSEN2, MAPT, PSEN1 TAAR1 935/4885ALDH1A1 675/4885CHKA 1157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.